• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Mumbai April 23 Wockhardt Ltd is set to bring anti-wrinkle products into the domestic market through its in-licensing deal with Milan-based Syrio Pharma SPA to market its B-Lift range of dermatology products.

The B-Lift range of products are based on a Botox-like peptide used for anti-ageing, said a Wockhardt note. Unlike Botox (a neuro-muscular injection), B-Lift is available in a gel form and can be used on all patients, the note added.

B-lift will be marketed locally by Wockhardt and its range of products will include a topical application gel for men, the company said.

And like the scar treatment, Wockhardt plans to launch B-Lift too in the third quarter of 2007. The product was first launched in 2003 in Italy.

More Stories on : Announcements | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
IOC non-fuel retail initiatives gather pace

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line